|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| C07K 14/005 | |||
| C07K 14/71 |
| (11) | Number of the document | 2755677 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12758868.9 |
| Date of filing the European patent application | 2012-09-14 | |
| (97) | Date of publication of the European application | 2014-07-23 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/068110 |
| Date | 2012-09-14 |
| (87) | Number | WO 2013/037961 |
| Date | 2013-03-21 |
| (30) | Number | Date | Country code |
| 201161535124 P | 2011-09-15 | US |
| (72) |
MICHAELIS, Uwe, DE
JENSEN-JAROLIM, Erika, AT
REHFUESS, Christoph, DE
WEGHOFER, Margit, AT
|
| (73) |
Medigene AG,
Lochhamer Strasse 11, 82152 Planegg/Martinsried,
DE
Biomedical International R + D GmbH, Wagramer Strasse 19, 1220 Wien, AT |
| (54) | ANTI-HER2 VACCINE BASED UPON AAV DERIVED MULTIMERIC STRUCTURES |
| ANTI-HER2 VACCINE BASED UPON AAV DERIVED MULTIMERIC STRUCTURES |